Athersys, Inc. is an international biotechnology company that is focused primarily in the field of regenerative medicine. The Company's MultiStem cell therapy, an allogeneic stem cell product, is its lead platform product and is in later-stage clinic... Read more
Access to easy in-depth stock analysis and reports from Refinitiv with analyst estimates on share price movements.